A novel monoclonal antibody against human thymic stromal lymphopoietin for the treatment of TSLP-mediated diseases

胸腺基质淋巴细胞生成素 免疫学 单克隆抗体 人性化鼠标 过敏性炎症 抗体 炎症 医学 免疫系统
作者
Lihua Shi,Mingcan Yu,Ying Jin,Peng Chen,Guangmao Mu,Susan H. Tam,Minseon Cho,Mark A. Tornetta,Chao Han,Man‐Cheong Fung,Mark L. Chiu,Di Zhang
出处
期刊:Frontiers in Immunology [Frontiers Media]
卷期号:15: 1442588-1442588 被引量:11
标识
DOI:10.3389/fimmu.2024.1442588
摘要

Introduction Thymic stromal lymphopoietin (TSLP) is a master regulator of allergic inflammation against pathogens at barrier surfaces of the lung, skin, and gut. However, aberrant TSLP activity is implicated in various allergic, chronic inflammation and autoimmune diseases and cancers. Biologics drugs neutralizing excess TSLP activity represented by tezepelumab have been approved for severe asthma and are being evaluated for the treatments of other TSLP-mediated diseases. Methods and results In this study, we discovered and characterized a novel humanized anti-TSLP antibody TAVO101 with high binding affinity to human TSLP, which blocks TSLP binding to its receptor complexes on cell surface. TAVO101 showed potent neutralization of TSLP activities in the TSLP-driven STAT5 reporter assay and cell proliferation assay. Results from ex vivo studies showed that TAVO101 neutralized TSLP-mediated CCL17 release from primary human CD1c+ dendritic cells and proliferation of activated CD4+ T cells. In addition, TAVO101 showed strong efficacy in both TSLP/OVA-induced asthma and imiquimod induced psoriasis models in hTSLP/hTSLPR double knock-in mice. We further conducted Fc engineering to optimize TAVO101 antibody with reduced affinity to Fcγ receptors and C1q protein but with increased affinity to FcRn receptor for half-life extension. Discussion By recognizing a different epitope, similarly potent neutralization of TSLP activities, and longer circulating half-life than tezepelumab, novel anti-TSLP antibody TAVO101 offers a potential best-in class therapeutics for various TSLP-mediated diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
JamesPei的应助被暨南伱采纳,获得30
1秒前
Ian完成签到,获得积分10
1秒前
1秒前
2秒前
欧斯奥特曼完成签到 ,获得积分10
2秒前
2秒前
sunsuan发布了新的文献求助10
2秒前
3秒前
王伟发布了新的文献求助10
3秒前
深情安青的应助被温暖砖头采纳,获得10
4秒前
4秒前
CodeCraft的应助被Gloria2023采纳,获得10
5秒前
路阳完成签到 ,获得积分10
5秒前
Akim的应助被热情的远锋采纳,获得10
5秒前
5秒前
xxx发布了新的文献求助10
5秒前
顺利怜菡发布了新的文献求助30
6秒前
xiongxiangyu123完成签到,获得积分20
6秒前
程朗发布了新的文献求助10
6秒前
cell完成签到,获得积分10
6秒前
7秒前
NexusExplorer的应助被踏实的青易采纳,获得10
7秒前
丘比特的应助被浮云采纳,获得10
8秒前
狂野元冬完成签到 ,获得积分10
8秒前
jinge发布了新的文献求助10
8秒前
9秒前
Hello的应助被简单的飞凤采纳,获得10
9秒前
烟花的应助被pinkangel采纳,获得10
9秒前
9秒前
10秒前
10秒前
11秒前
Sissi发布了新的文献求助30
11秒前
11秒前
11秒前
王伟完成签到,获得积分10
12秒前
共享精神的应助被hailiangzheng采纳,获得10
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183241
求助须知:如何正确求助?哪些是违规求助? 9572493
关于积分的说明 21826218
捐赠科研通 7780115
什么是DOI,文献DOI怎么找? 3433982
关于科研通互助平台的介绍 2558103
邀请新用户注册赠送积分活动 2480192